Evidence map›Paper›PMID 34639778›Full record

Trial reportInternational journal of environmental research and public health2021

Effect of Phenol Application Time in the Treatment of Onychocryptosis: A Randomized Double-Blind Clinical Trial.

Juan Manuel Muriel-Sánchez, Manuel Coheña-Jiménez, Pedro Montaño-Jiménez

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. [Ingrown toenail: when and how to treat?]Dermatologie (Heidelberg, Germany) · 2025
    Article
  4. Clinical aspects and risks of the phenol/croton oil.Experimental and therapeutic medicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Juan Manuel Muriel-SánchezDepartamento de Podología, Facultad de Enfermería, Fisioterapia y Podología, Universidad de Sevilla, Calle Avicena s/n, 41009 Sevilla, Spain.
Manuel Coheña-JiménezDepartamento de Podología, Facultad de Enfermería, Fisioterapia y Podología, Universidad de Sevilla, Calle Avicena s/n, 41009 Sevilla, Spain.ORCID 0000-0001-5714-6594
Pedro Montaño-JiménezDepartamento de Podología, Facultad de Enfermería, Fisioterapia y Podología, Universidad de Sevilla, Calle Avicena s/n, 41009 Sevilla, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the treatment of Onychocryptosis, chemical matricectomy with 88% phenol solution is one of the most common surgical procedures due to a recurrence rate of less than 5%, but it may produce a delay in healing time. The objective was to compare the healing time between phenol applications of 30 or 60 s.

methodsA comparative, prospective, parallel, randomized, and blinded clinical trial was registered with the European Clinical Trials Database. Twenty-seven patients (54 feet) with 108 affected nail folds were randomized and treated with chemical matricectomy with phenol. Each hallux was randomly assigned to one of two groups (60 vs. 30 s phenolization). Each patient and one investigator were blinded to the phenol application time in each foot. The outcome measurements were healing time, recurrence, pain, post-surgical bleeding, inflammation, and infection rate.

resultsThe 30 s application presents a shorter healing time (14.93 ± 2.81 days vs. 22.07 ± 3.16 days;

conclusionsThe 30 s phenol application time offers a shorter healing time than 60 s without affecting the effectiveness of the procedure, showing the same rate of complications.

Indexed as

Nails, IngrownDouble-Blind MethodHumansPhenolPhenolsProspective StudiesPhenolPhenolschemical matricectomyfoot pathologiesingrown toenailonychocryptosisphenol

Identifiers

PMID34639778
PMCPMC8508160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.